Prelude Capital Management’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Sell |
91,504
-57,871
| -39% | -$755K | 0.12% | 220 |
|
|
2025
Q1 | $2.22M | Sell |
149,375
-49,185
| -25% | -$732K | 0.17% | 115 |
|
|
2024
Q4 | $3.61M | Buy |
+198,560
| New | +$3.61M | 0.23% | 68 |
|
|
2022
Q2 | – | Sell |
-24,898
| Closed | -$540K | – | 1587 |
|
|
2022
Q1 | $540K | Buy |
+24,898
| New | +$540K | 0.02% | 649 |
|
|
2020
Q4 | – | Sell |
-2,818
| Closed | -$18K | – | 886 |
|
|
2020
Q3 | $18K | Buy |
2,818
+900
| +47% | +$5.75K | ﹤0.01% | 1012 |
|
|
2020
Q2 | $12K | Hold |
1,918
| – | – | ﹤0.01% | 1037 |
|
|
2020
Q1 | $13K | Buy |
1,918
+628
| +49% | +$4.26K | ﹤0.01% | 714 |
|
|
2019
Q4 | $15K | Sell |
1,290
-1,910
| -60% | -$22.2K | ﹤0.01% | 1193 |
|
|
2019
Q3 | $33K | Buy |
+3,200
| New | +$33K | ﹤0.01% | 860 |
|
|
2018
Q3 | – | Sell |
-3,246
| Closed | -$37K | – | 1377 |
|
|
2018
Q2 | $37K | Buy |
+3,246
| New | +$37K | ﹤0.01% | 948 |
|
|
2017
Q4 | – | Sell |
-9,488
| Closed | -$135K | – | 1246 |
|
|
2017
Q3 | $135K | Buy |
9,488
+1,207
| +15% | +$17.2K | 0.01% | 712 |
|
|
2017
Q2 | $107K | Sell |
8,281
-10,254
| -55% | -$132K | 0.01% | 684 |
|
|
2017
Q1 | $266K | Sell |
18,535
-16,444
| -47% | -$236K | 0.03% | 424 |
|
|
2016
Q4 | $546K | Buy |
34,979
+9,596
| +38% | +$150K | 0.07% | 279 |
|
|
2016
Q3 | $299K | Buy |
25,383
+22,027
| +656% | +$259K | 0.03% | 387 |
|
|
2016
Q2 | $47K | Sell |
3,356
-13,310
| -80% | -$186K | 0.01% | 981 |
|
|
2016
Q1 | $194K | Buy |
16,666
+1,966
| +13% | +$22.9K | 0.03% | 506 |
|
|
2015
Q4 | $241K | Buy |
14,700
+13,700
| +1,370% | +$225K | 0.04% | 429 |
|
|
2015
Q3 | $14K | Buy |
+1,000
| New | +$14K | ﹤0.01% | 1205 |
|
|
2015
Q1 | – | Sell |
-1,962
| Closed | -$24K | – | 1866 |
|
|
2014
Q4 | $24K | Buy |
+1,962
| New | +$24K | ﹤0.01% | 1582 |
|
|
2014
Q1 | – | Sell |
-8,594
| Closed | -$86K | – | 1684 |
|
|
2013
Q4 | $86K | Buy |
+8,594
| New | +$86K | 0.01% | 830 |
|